Goodman Group Valuation

Is MY4 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MY4 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MY4 (€21.64) is trading below our estimate of fair value (€24.71)

Significantly Below Fair Value: MY4 is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for MY4?

Other financial metrics that can be useful for relative valuation.

MY4 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue60.4x
Enterprise Value/EBITDA-289.2x
PEG Ration/a

Price to Book Ratio vs Peers

How does MY4's PB Ratio compare to its peers?

The above table shows the PB ratio for MY4 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average1.9x
LINE Lineage
3.4x71.2%US$18.2b
PLD Prologis
2x4.3%US$106.8b
SGRO SEGRO
0.9x37.5%UK£10.6b
A17U CapitaLand Ascendas REIT
1.2x23.0%S$11.9b
MY4 Goodman Group
4x27.8%€69.8b

Price-To-Book vs Peers: MY4 is expensive based on its Price-To-Book Ratio (4x) compared to the peer average (1.9x).


Price to Earnings Ratio vs Industry

How does MY4's PE Ratio compare vs other companies in the Global Industrial REITs Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a0%
n/an/an/a
No. of CompaniesPB048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a0%
n/an/an/a
No more companies

Price-To-Book vs Industry: MY4 is expensive based on its Price-To-Book Ratio (4x) compared to the Global Industrial REITs industry average (0.9x).


Price to Book Ratio vs Fair Ratio

What is MY4's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MY4 PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio4x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate MY4's Price-To-Book Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst MY4 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€21.61
€22.58
+4.5%
12.8%€25.71€14.55n/a11
Oct ’25€22.63
€22.38
-1.1%
12.8%€25.27€14.90n/a11
Sep ’25€20.02
€20.55
+2.6%
17.7%€24.14€11.97n/a12
Aug ’25€21.62
€20.06
-7.2%
17.3%€24.14€11.97n/a12
Jul ’25€22.30
€20.26
-9.1%
17.5%€24.79€12.29n/a12
Jun ’25€20.10
€19.37
-3.6%
15.9%€23.22€12.21n/a12
May ’25€18.83
€18.00
-4.4%
15.6%€21.45€11.95n/a13
Apr ’25€19.93
€17.89
-10.3%
15.4%€21.07€11.99n/a13
Mar ’25€17.93
€17.67
-1.4%
14.3%€20.69€12.02n/a13
Feb ’25€14.99
€15.49
+3.4%
8.7%€17.17€11.72n/a12
Jan ’25€15.27
€15.10
-1.1%
9.4%€17.36€11.86n/a12
Dec ’24€13.68
€14.55
+6.4%
12.3%€17.13€10.45n/a13
Nov ’24€12.44
€14.26
+14.6%
11.4%€16.74€10.35€21.6413
Oct ’24€12.82
€14.65
+14.3%
11.3%€16.96€10.49€22.6313
Sep ’24€13.43
€14.07
+4.8%
11.8%€16.78€10.38€20.0214
Aug ’24€12.26
€13.62
+11.1%
10.3%€15.29€10.65€21.6214
Jul ’24€11.98
€13.69
+14.3%
9.3%€15.00€10.70€22.3014
Jun ’24€11.78
€13.39
+13.7%
9.4%€14.76€10.54€20.1013
May ’24€11.32
€13.69
+21.0%
7.2%€14.78€11.41€18.8312
Apr ’24€11.30
€13.96
+23.5%
7.7%€15.11€11.66€19.9312
Mar ’24€12.10
€13.96
+15.4%
8.2%€15.27€11.78€17.9313
Feb ’24€12.86
€13.91
+8.2%
8.6%€16.02€11.72€14.9913
Jan ’24€10.81
€13.84
+28.0%
9.5%€15.95€11.67€15.2714
Dec ’23€12.27
€13.84
+12.7%
9.5%€15.95€11.67€13.6814
Nov ’23€11.19
€15.47
+38.2%
8.9%€17.33€12.28€12.4414

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies